In a newly released video, Attorney General Jeff Sessions said to a Department of Justice intern, “Look, there’s this view that marijuana is harmless and does no damage . . . Marijuana is not a healthy substance in my opinion. The American Medical Association is crystal clear on that. Do you believe that? [The intern said no.] Well, you can write the AMA and see why.” See the full video at ABC.

We wrote the AMA and received their most up-to-date policies on cannabis.

A document from the American Medical Association House of Delegates shows that these policies have changed slightly since September 2016, when the organization resolved to scratch that the “sale of cannabis should not be legalized.”AMA

Latest Gallup poll: Americans favor marijuana legalization more than ever


AMA Policy on Cannabis 2017:

Cannabis Legalization for Recreational Use

Our AMA: (1) believes that cannabis is a dangerous drug and as such is a serious public health concern; (2) believes that the sale of cannabis for recreational use should not be legalized; (3) discourages cannabis use, especially by persons vulnerable to the drug’s effects and in high-risk populations such as youth, pregnant women, and women who are breastfeeding; (3) believes states that have already legalized cannabis (for medical or recreational use or both) should be required to take steps to regulate the product effectively in order to protect public health and safety and that laws and regulations related to legalized cannabis use should consistently be evaluated to determine their effectiveness; (5) encourages local, state, and federal public health agencies to improve surveillance efforts to ensure data is available on the short- and long-term health effects of cannabis use; (6) supports public health based strategies, rather than incarceration, in the handling of individuals possessing cannabis for personal use.

Cannabis and Cannabinoid Research

(1) Our AMA calls for further adequate and well-controlled studies of marijuana and related cannabinoids in patients who have serious conditions for which preclinical, anecdotal, or controlled evidence suggests possible efficacy and the application of such results to the understanding and treatment of disease. (2) Our AMA urges that marijuana’s status as a federal schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product. (3) Our AMA urges the National Institutes of Health (NIH), the Drug Enforcement Administration (DEA), and the Food and Drug Administration (FDA) to develop a special schedule and implement administrative procedures to facilitate grant applications and the conduct of well-designed clinical research involving cannabis and its potential medical utility. This effort should include: a) disseminating specific information for researchers on the development of safeguards for cannabis clinical research protocols and the development of a model informed consent form for institutional review board evaluation; b) sufficient funding to support such clinical research and access for qualified investigators to adequate supplies of cannabis for clinical research purposes; c) confirming that cannabis of various and consistent strengths and/or placebo will be supplied by the National Institute on Drug Abuse to investigators registered with the DEA who are conducting bona fide clinical research studies that receive FDA approval, regardless of whether or not the NIH is the primary source of grant support. (4) Our AMA supports research to determine the consequences of long-term cannabis use, especially among youth, adolescents, pregnant women, and women who are breastfeeding. (5) Our AMA urges legislatures to delay initiating the legalization of cannabis for recreational use until further research is completed on the public health, medical, economic, and social consequences of its use.

Cannabis Legalization for Medicinal Use

Our AMA: (1) believes that scientifically valid and well-controlled clinical trials conducted under federal investigational new drug applications are necessary to assess the safety and effectiveness of all new drugs, including potential cannabis products for medical use; (2) believes that cannabis for medicinal use should not be legalized through the state legislative, ballot initiative, or referendum process; (3) will develop model legislation requiring the following warning on all cannabis products not approved by the U.S. Food and Drug Administration: “Marijuana has a high potential for abuse. This product has not been approved by the Food and Drug Administration for preventing or treating any disease process.”; (4) supports legislation ensuring or providing immunity against federal prosecution for physicians who certify that a patient has an approved medical condition or recommend cannabis in accordance with their state’s laws; and (5) believes that effective patient care requires the free and unfettered exchange of information on treatment alternatives and that discussion of these alternatives between physicians and patients should not subject either party to criminal sanctions.


New York State Department of Health Announces New Medical Marijuana Regulations

ALBANY, N.Y., Dec. 8, 2017 /Weed Wire/ — The New York State Department of Health today announced the filing of regulations for adoption that will improve the state’s Medical Marijuana Program for patients, practitioners and registered organizations. These regulations, which will go into effect on December 27, 2017, allow for the sale of additional medical marijuana products, an improved experience for patients and visitors at dispensing facilities and the ability for the Department to approve new courses that will allow prospective practitioners to complete their training in a shorter amount of time.

The Department previously announced the introduction of these regulations in August 2017.

New York State Department of Health Commissioner Dr. Howard Zucker

“Ensuring access to medical marijuana for eligible patients is central to the Department’s efforts to responsibly grow New York’s Medical Marijuana Program,” said New York State Department of Health Commissioner Dr. Howard Zucker. “The new regulations will benefit current and prospective patients and practitioners, as well as registered organizations, and continue to build on the progress the program has made since its launch nearly two years ago.”

Under the new regulations, registered organizations (ROs) are allowed to manufacture and distribute additional products including topicals such as ointments, lotions and patches; solid and semi-solid products, including chewable and effervescent tablets and lozenges; and certain non-smokable forms of ground plant material. All products are subject to rigorous testing, and the Department reserves the right to exclude inappropriate products or those which pose a threat to public health.

The new regulations also allow prospective patients and practitioners to enter dispensing facilities to speak directly with RO representatives, learn about products and get information about the medical marijuana program. In addition, people other than designated caregivers may accompany patients to dispensing facilities.

Under these regulations, practitioners will soon be able to take a shortened version of the currently available four-hour courses required to certify patients for medical marijuana. The Department will work with course providers to offer a two-hour course, which is a typical length for other medical education courses.

The regulations also streamline the manufacturing requirements for medical marijuana products, broaden the capability of registered organizations to advertise, amend security requirements and clarify laboratory testing methods.

Other recent enhancements to New York’s Medical Marijuana Program include authorizing five additional registered organizations to manufacture and dispense medical marijuana, adding post-traumatic stress disorder and chronic pain as qualifying conditions, empowering nurse practitioners and physician assistants to certify patients and permitting home delivery.

As of December 8, 2017, there are 38,642 certified patients and 1,358 registered practitioners participating in the program.

For more information on New York’s Medical Marijuana Program, visit:

Woman cuts off cop, parks in police chief’s spot while smoking weed and talking on phone

By The Associated Press

NORTHPORT, N.Y. Authorities say a woman arriving at a Long Island court to answer a marijuana possession summons was smoking pot when she parked her vehicle in the local police chief’s spot.

Newsday reports that the 26-year-old woman had been ticketed in May for unlawful possession of marijuana. Police say she was arriving for her court appearance in Northport on Monday night when she cut off an unmarked police car in the parking lot while talking on her cellphone.

Police say she then pulled into the parking spot clearly marked as reserved for the village’s police chief, Bill Ricca. He says when the officers asked the woman to roll down her window, pot smoke billowed out.

Police issued the woman another appearance ticket for unlawful possession of marijuana. She was also ticketed for using her cellphone while driving.

Information from: Newsday




In attempt to help small farmers, Humboldt reps call for one-acre cap on cannabis cultivation

By Will Houston, The Cannifornian

The North Coast’s two state representatives are calling on the state to cap commercial cannabis farms to one acre per person, saying it will protect small farmers from being outcompeted by larger companies.

However, some in the industry are saying reinstating the cap so close to the planned New Year’s Day rollout of the state’s marijuana market would be inappropriate timing, with some farms having already been permitted at the local level to grow more than one acre.

Second District Sen. Mike McGuire

Second District Sen. Mike McGuire and Assemblyman Jim Wood  sent a letter to the Office of Administrative Law earlier this week that called for the cap to be included in the state’s cannabis regulations, which are currently being finalized.

Assemblyman Jim Wood

Wood said not having the cap goes against previous efforts by the Legislature to limit cultivation in the Medical Cannabis Regulation and Safety Act, which limited cultivation to one acre with an exception for a dispensary license that allowed up to four acres of cultivation

“It undermines the work that we were doing to protect the smaller growers at least at the outset,” Wood said outside of the Humboldt County Board of Supervisors chambers in Eureka on Tuesday. “We know that five years from now all bets are off, but we’ve got to give the people who are the real pioneers in this industry an opportunity to be successful and a way to bring them out of the shadows and into the regulated market.”

After the passage of recreational marijuana laws through Proposition 64 in November 2016 and the Legislature combining the medical and recreational rules through Senate Bill 94 earlier this year, the one-acre cultivation limit was left out.

The California Department of Food and Agriculture then released its emergency cannabis cultivation rules last month, which also did not include the one-acre cap. However, an environmental review of the rules released a few days earlier had included the cap.

The Department of Food and Agriculture told the Times-Standard at the time that it “left out” the cap from the final rules “after careful consideration, including input from stakeholders.”

California Growers Association Executive Director Hezekiah Allen said he met with staff from Gov. Jerry Brown’s office on Tuesday who he said told him that there never was going to be a cumulative cap on cultivation. Allen said he walked away from the meeting with the impression that the governor’s office was disowning the Department of Food and Agriculture’s November statement to the Times-Standard.

“I’m a bit confused frankly. It just seems inconsistent,” Allen said.

Federal marijuana protections safe for now with stopgap spending bill

“While we are pleased that these critical protections will continue, two weeks is not enough certainty for the millions of Americans who rely on medical marijuana,” said Rep. Earl Blumenauer.


President Donald Trump signed a stopgap spending bill Friday to avoid a government shutdown and keep the federal government running through Dec. 22.

Protections for state medical marijuana programs known as the Rohrabacher-Blumenauer amendment were also continued in the legislation to fund the government, Rep. Earl Blumenauer, D-Ore., announced in a statement Thursday after the House passed the measure.

“While we are pleased that these critical protections will continue, two weeks is not enough certainty for the millions of Americans who rely on medical marijuana for treatment and the businesses who serve them,” Blumenauer said. “As Congress works out a long-term funding bill, it must also include these protections. And ultimately, Congress must act to put an end to the cycle of uncertainty and permanently protect state medical marijuana programs — and adult use — from federal interference.”


The extension of Rohrabacher-Blumenauer comes a week after a letter was made public in which 66 members of Congress urged Senate and House leaders to extend the medical marijuana protections that have been in place since December 2014. Those protections, previously known as Rohrabacher-Farr, prohibit the U.S. Department of Justice from using federal funds to prevent certain states “from implementing their own State laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

John Hudak

The likelihood of the Rohrabacher-Blumenauer amendment’s inclusion in a new omnibus bill is “pretty good,” said John Hudak, a drug policy specialist and senior fellow at the Brookings Institution in Washington, D.C., in an interview with The Cannabist earlier this week.

“We’ve been down this road before,” he said.

Although House members stymied efforts to include marijuana-related provisions — including Rohrabacher-Blumenauer — from the federal appropriations bill under consideration, there still exists avenues in the Senate for the insertion of Rohrabacher-Blumenauer, he added.

Additionally, stripping Rohrabacher-Blumenauer could have negative implications for Republicans’ efforts in trying to round up the necessary votes on the new tax bill, he said.

“It puts Congress in a position right now that if they start meddling significantly with upcoming spending legislation, it could put at risk this very fragile coalition that’s been put together on the tax bill,” Hudak said. “They probably have a lot more to lose by stripping it than they do to gain.”

The short-term continuing resolution should give Congress a few extra weeks to negotiate a broader omnibus appropriations bill that could then last for nine or 10 months, he said.


Since his confirmation as Attorney General on February 9th, 2017, rumors have swirled about Jeff Sessions and his justice department’s expected treatment of marijuana and the states where it is legal.


It is well known that the federal government does not view marijuana favorably and still does not believe there is any acceptable medical use for the plant. What we do not know concretely is how the new administration and justice department under Jeff Sessions will act on those archaic beliefs.


According to reports, Mr. Sessions sent a letter to Congress in May asking for the removal of the Rohrabacher-Farr amendment from the next federal budget. The amendment protects medical marijuana states by disallowing the DEA from spending even a dime on prosecuting states where medical marijuana is legal.


threatens Marijuana state lawsSessions, stated “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime,” as his reasoning for the request.


Luckily, for the sake and safety of many medical marijuana patients, the Senate recently struck down Sessions letter. The Senate appropriations committee decided that it would be wasteful and useless to spend federal government funds on prosecuting medical marijuana states due to the Attorney General’s pseudo-scientific views of marijuana.

Vermont Senator Patrick Leahy

One of the Senators on the appropriations committee, Patrick Leahy of Vermont stated, “I don’t want them spending money pursuing medical marijuana patients who are following state law, whether they’re an epileptic or whatever they might be.”

Senator Leahy is one of the many American citizens who believes that Sessions is overstepping his judicial duties in attempting to impose his personal views upon the civil liberties of millions of people. It’s been said before but it must continue to be said, Attorney General Jeff Sessions must either resign or openly state his confidence in the laws and regulations of the states when it comes to medical marijuana.


For far too long, people who suffer from post-traumatic stress syndrome have had to deal with the debilitating symptoms of the condition with little successful treatment. One treatment that is gaining increased popularity among veterans and other people with Post Traumatic Stress Disorder (PTSD), is the use of medical marijuana.


Marijuana For PTSD TreatmentConsidering the fact that 20 veterans commit suicide every day in the United States, there is a clear need for a new form of treatment for people who suffer from PTSD.

As Dr. Sue Sisley, the psychiatrist who is leading the first randomized, controlled trial of the ability for cannabis to treat post-traumatic stress syndrome states, “I eventually started to see that a lot of these veterans were not responding to conventional medications, and then I began seeing a lot of deaths in my practice…these were people who had already been through the gauntlet of medications and nothing had helped.”

As Dr. Sisley explains, the traditional anti-depressants and anti-anxiety medications given to people with PTSD often end up causing more harm than help. Many veterans and others who have tried marijuana are actually able to slowly ween themselves off of the harsh mix of medications that they take on a daily basis.


The science behind why marijuana could help ease the effects of PTSD is actually very simple. One of the main symptoms of PTSD is an endocannabinoid deficiency. In people with PTSD, the body does not produce enough endocannabinoids to sufficiently fill cannabinoid receptors. Marijuana counteracts the symptoms of endocannabinoid deficiency by introducing cannabinoids from outside of the body that act as a replacement for the decreased production of cannabinoids in the body.

While there is overwhelming scientific and anecdotal evidence proving the efficacy of marijuana in treating post-traumatic stress syndrome, many people still don’t have access to it. For residents of Colorado however, that is changing.


Colorado PTSD Cannabis TreatmentColorado lawmakers recently passed a bill making Colorado one of about 16 states which consider PTSD an eligible condition for treatment with medical marijuana. This huge step forward will finally allow Colorado citizens who suffer from PTSD to access the medicine they deem best fit to treat their condition. Hopefully more of the 29 states with established legal medical marijuana programs will consider the needs of veterans and others who have to live with PTSD and establish it as an accepted condition.While Colorado and other states are pushing forward by making PTSD an eligible condition for medical marijuana use, there are still many restrictions in place making it hard or even impossible for people to access the medicine they need. The fight must continue until everyone with PTSD has the chance to treat their condition with the safest and most effective medicine possible.



Houston D.A Says It “Doesn’t Make Sense” To Prosecute Marijuana Offenses- The State of Texas as a whole is one of the most anti-marijuana states. The state does offer medical marijuana for those suffering from intractable epilepsy and other chronic diseases after passing the Compassionate Use Act in June 2015. However, those caught using or distributing marijuana without the proper identification can still face charges for carrying even the smallest amounts of weed.

Currently, in Texas, persons found with less than two ounces of marijuana can face a misdemeanor charge and up to 180 days in jail. Perpetrators caught with between two and four ounces of pot may be sentenced to at least a year in jail, while those caught with more than four ounces of marijuana face felony charges and jail sentences between two and 99 years.


Kim Ogg – the newly elected District Attorney of Houston’s New Harris County

In Houston marijuana is illegal, but the enforcement of the the law is changing. Last week, Kim Ogg – the newly elected District Attorney of Houston’s New Harris County vowed to uphold her campaign promise to reform marijuana laws.

enforcers want to enforce the law differently. Last week, Kim Ogg – the newly elected District Attorney of Houston’s New Harris County – vowed to uphold her campaign promise to reform marijuana laws. From Kim Oggs campaign site ‘Ogg’s marijuana platform reflects common sense drug prosecution policies that mirror the concerns of ordinary citizens who are tired of hearing that the police and prosecutors don’t have the time to investigate and prosecute home burglaries, or the resources to test backlogged rape kits. Ogg’s plan is to increase public safety by keeping law enforcement on the street instead of wasting time arresting those in possession of small amounts of marijuana.’

“Gangs and organized crime groups are running rampant in Harris County, and I want law enforcement to have the time and money necessary to dismantle those operations. Every time they arrest someone in possession of marijuana, police are off the streets for an average of four hours.” — Kim Ogg

“I’ve never felt good about putting marijuana users in the same jail cells as murderers,” Ogg said after being sworn into office last Monday. “It’s just not fair, it doesn’t make any sense, and our country is resoundingly against that.”So she vows to ensure that “all misdemeanor possession of marijuana cases will be diverted around jail.”

Houston’s new Police Chief, Art Acevedo, added that steps toward decriminalization could open the door to legalizing medical marijuana in Texas.

Houston’s new Police Chief, Art Acevedo

“I think you’ll have a really spirited but well-informed discussion, and at some point I could really foresee, in the future, marijuana and some other oils being legalized for medicinal purposes,” Chief Acevedo said. “It will probably be the first step in Texas.”

Ridete! Fa bene alla salute, aiuta a bruciare calorie e ad essere più efficienti sul lavoro

MetropoliZ blog

articolo di Valentina Arcovio
È scientificamente dimostrato: migliora la circolazione del sangue, previene le malattie cardiovascolari, tiene il cervello allenato, contrasta ansia e depressione e contribuisce alla salute del sistema immunitario
C’è un modo semplice ed economico per vivere di più e meglio: ridere. E’ infatti scientificamente dimostrato che ridere è una sorta di elisir che allunga e migliora la nostra vita. E non c’è giorno migliore di questo, che è la Giornata mondiale della risata, per imparare o riprendere a farlo. Proprio come se fosse una medicina o almeno così la considerano esperti e scienziati provenienti da ogni parte del mond o, il cui parere è stato analizzato da uno studio condotto da Espresso Communication su oltre 70 testate internazionali.

La Giornata mondiale della risata è nata nel 1998 come manifestazione a favore della pacesu iniziativa del medico indiano…

View original post 959 altre parole